Filing Details
- Accession Number:
- 0001127602-14-030037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-17 16:24:42
- Reporting Period:
- 2014-10-15
- Filing Date:
- 2014-10-17
- Accepted Time:
- 2014-10-17 16:24:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 932052 | D M J Harvey Berger | C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-15 | 12,500 | $5.10 | 1,751,786 | No | 4 | P | Indirect | Ocean Capital Partners, Llc |
| Common Stock | Acquisiton | 2014-10-16 | 12,500 | $5.39 | 1,764,286 | No | 4 | P | Indirect | Ocean Capital Partners, Llc |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Ocean Capital Partners, Llc |
| No | 4 | P | Indirect | Ocean Capital Partners, Llc |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 246,054 | Indirect | Daughter |
| Common Stock | 248,745 | Indirect | Daughter |
| Common Stock | 245,251 | Indirect | Wife |
| Common Stock | 1,163,564 | Direct |
Footnotes
- Shares were aquired pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.04 to $5.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote.
- The reporting person is a managing member of this LLC.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.34 to $5.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
